We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current PLSE market cap is 1.05B. The company's latest EPS is USD -0.6862 and P/E is -25.05.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -11.25M | -12.53M | -10.62M | -11.73M | -13.66M |
| Net Income | -10.57M | -11.93M | -10.14M | -11.38M | -12.68M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 1.42M | 700k | 0 |
| Operating Income | -47.95M | -49.97M | -63.01M | -58.06M | -43.57M |
| Net Income | -46.97M | -49.85M | -63.66M | -58.51M | -42.21M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 65.95M | 59.15M | 49.16M | 40.43M | 93.05M |
| Total Liabilities | 13.8M | 14.79M | 12.88M | 13.46M | 13.92M |
| Total Equity | 52.15M | 44.36M | 36.29M | 26.97M | 79.13M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 41.92M | 41.29M | 54.25M | 77.88M | 59.15M |
| Total Liabilities | 11.18M | 18.4M | 18.56M | 80.13M | 14.79M |
| Total Equity | 30.74M | 22.89M | 35.69M | -2.25M | 44.36M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -26.26M | -33.04M | -9.78M | -18.18M | -27.2M |
| Investing | -78k | -121k | -5k | -34k | -72k |
| Financing | 15.58M | 16.39M | 305k | 40k | 61.94M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -34.19M | -35.37M | -54.1M | -47.01M | -33.04M |
| Investing | -10.1M | 10.04M | 7.56M | -401k | -121k |
| Financing | 82k | 30.89M | 62.69M | 79.94M | 16.39M |
| Market Cap | 1.05B |
| Price to Earnings Ratio | -25.05 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 23.84 |
| Price to Book Ratio | 23.84 |
| Dividend Yield | - |
| Shares Outstanding | 61.52M |
| Average Volume (1 week) | 112.77k |
| Average Volume (1 Month) | 142.48k |
| 52 Week Change | 115.04% |
| 52 Week High | 22.69 |
| 52 Week Low | 6.595 |
| Spread (Intraday) | 0.75 (4.23%) |
| Company Name | Pulse Biosciences Inc |
| Address |
corporation trust center 1209 orange st wilmington, delaware 19801 |
| Website | https://www.pulsebiosciences.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
